Galit Alter
Impact in
- Virology top 0.02%
- HIV Research and Treatment
- Infectious Diseases top 0.02%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Tuberculosis Research and Epidemiology
Papers in
- Virology 170
- HIV Research and Treatment 167
-
- SARS-CoV-2 and COVID-19 Research 115
- Tuberculosis Research and Epidemiology 29
- Viral Infections and Outbreaks Research 25
- Co-authors
- Altfeld Marcus (45 shared papers)Jessica Malenfant (2 shared papers)Hendrik Streeck (50 shared papers)Todd J. Suscovich (34 shared papers)Margaret E. Ackerman (45 shared papers)Sarah M. Fortune (15 shared papers)Lenette L. Lu (8 shared papers)Madeleine F. Jennewein (12 shared papers)
- Journals
- Journal of Virology (33 papers)The Journal of Infectious Diseases (24 papers)Cell (21 papers)Frontiers in Immunology (18 papers)Science Translational Medicine (17 papers)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Galit Alter
494 papers receiving 39.3k citations
Galit Alter's Hit Papers
Peers
Comparison fields: 5 of 171
- Virology 8.8k
- Infectious Diseases 16k
- Immunology 6.5k
- Obstetrics and Gynecology 1.2k
- Radiology, Nuclear Medicine and Imaging 2k
Countries citing papers authored by Galit Alter
This map shows the geographic impact of Galit Alter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Galit Alter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Galit Alter more than expected).
Fields of papers citing papers by Galit Alter
This network shows the impact of papers produced by Galit Alter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Galit Alter. The network helps show where Galit Alter may publish in the future.
Co-authors
The 25 scholars most cited alongside Galit Alter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 498 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | CD107a as a functional marker for the identification of natural killer cell activity Hit paper breakdown → | 2004 | 1208 |
| 2 | Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host Hit paper breakdown → | 2020 | 933 |
| 3 | Correlates of protection against SARS-CoV-2 in rhesus macaques Hit paper breakdown → | 2020 | 876 |
| 4 | 2020 | 827 | |
| 5 | 2020 | 683 | |
| 6 | 2020 | 660 | |
| 7 | 2020 | 651 | |
| 8 | Beyond binding: antibody effector functions in infectious diseases Hit paper breakdown → | 2017 | 617 |
| 9 | 2020 | 564 | |
| 10 | 2020 | 559 | |
| 11 | Coronavirus disease 2019 vaccine response in pregnant and lactating women: a cohort study Hit paper breakdown → | 2021 | 537 |
| 12 | Sex differences in the Toll-like receptor–mediated response of plasmacytoid dendritic cells to HIV-1 Hit paper breakdown → | 2009 | 511 |
| 13 | 2020 | 492 | |
| 14 | 2020 | 485 | |
| 15 | Antibiotics-Driven Gut Microbiome Perturbation Alters Immunity to Vaccines in Humans Hit paper breakdown → | 2019 | 468 |
| 16 | A Functional Role for Antibodies in Tuberculosis Hit paper breakdown → | 2016 | 464 |
| 17 | Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys Hit paper breakdown → | 2016 | 431 |
| 18 | Persistent Circulating Severe Acute Respiratory Syndrome Coronavirus 2 Spike Is Associated With Post-acute Coronavirus Disease 2019 Sequelae Hit paper breakdown → | 2022 | 410 |
| 19 | 2010 | 386 | |
| 20 | 2007 | 381 |
About Galit Alter
Galit Alter is a scholar working on Virology, Infectious Diseases, Immunology, Radiology, Nuclear Medicine and Imaging and Public Health, Environmental and Occupational Health, having authored 498 papers that have together received 40.1k indexed citations. Recurring topics across this work include HIV Research and Treatment (167 papers), SARS-CoV-2 and COVID-19 Research (115 papers), Monoclonal and Polyclonal Antibodies Research (43 papers), Immune Cell Function and Interaction (40 papers), Tuberculosis Research and Epidemiology (29 papers), Viral Infections and Outbreaks Research (25 papers), Immune responses and vaccinations (17 papers) and Glycosylation and Glycoproteins Research (12 papers). The work is most often cited by research in Virology (8.8k citations), Infectious Diseases (16k citations), Immunology (6.5k citations), Obstetrics and Gynecology (1.2k citations) and Radiology, Nuclear Medicine and Imaging (2k citations). Galit Alter has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Altfeld Marcus, Jessica Malenfant, Hendrik Streeck, Todd J. Suscovich, Margaret E. Ackerman, Sarah M. Fortune, Lenette L. Lu, Madeleine F. Jennewein, Anne‐Sophie Dugast and Mary N Carrington. Their work appears in journals such as Journal of Virology, The Journal of Infectious Diseases, Cell, Frontiers in Immunology and Science Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.